Recombinant Bone Morphogenetic Protein Receptor 1A (BMPR1A)

CD292; ACVRLK3; ALK3; SKR5; BMPR1-A; Activin A Receptor, Type Ii-Like Kinase 3; Activin Receptor-Like Kinase 3; Serine/Threonine-Protein Kinase Receptor R5

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-0.2 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA015Hu01 Recombinant Bone Morphogenetic Protein Receptor 1A (BMPR1A) Positive Control; Immunogen; SDS-PAGE; WB.
PAA015Hu01 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A) WB; IHC; ICC; IP.
MAA015Hu22 Monoclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A) WB; IHC; ICC; IP.